Company Overview and News

0
PSE index rebounds after early losses

2018-07-20 business.inquirer.net
The local stock barometer slightly rebounded yesterday, tracking an intraday recovery across regional markets after the initial jitters caused by the sharp decline in the value of the Chinese yuan.
ABZPF SMIVY PSKXF SVTMF ABZPY AYAAY PHSXY SM PSE ALI AYAAF AP

0
PSEi bounces back to 7,400 level

2018-07-18 business.inquirer.net
The local stock barometer yesterday rebounded to the 7,400 level as regional markets cheered the US Federal Reserve chief’s upbeat view on the US economy.
PSKXF SHAK AYAAY PHSXY PSE ALI AYAAF

0
DOTr wins some, loses some

2018-07-18 business.inquirer.net
Over the last two years, the Department of Transportation (DOTr) has embarked on a series of steps to improve the lives of the commuters, motorists and the public, in general—crack down on corruption, secure funding for legacy infrastructure projects and even move its headquarters to Clark, Pampanga.
ICT MWP AYAAY GMRINFRA GMQRY MWIDE ICTEF ALI 532754 AYAAF

0
Bourse ends at one-month peak on Fed cues

2018-07-18 bworldonline
THE Philippine Stock Exchange index (PSEi) finished at a one-month high on Wednesday, drawing strength from Wall Street’s rise on Federal Reserve Chairman Jerome Powell’s optimistic remarks on the US economy and solid earnings results.
SMIVY SSI SHAK SVTMF MWP AYAAY SM MWIDE ALI AYAAF

0
Stocks edge higher after Fed chair’s ‘dovish’ remarks

2018-07-18 bworldonline
Shares advanced on Wednesday, July 18, boosted by the positive performance of international markets after United States Federal Reserve Chairman Jerome Powell hinted at more flexible changes in monetary policy.
SVTMF PSKXF AYAAY SM SMIVY SSI SHAK MWP PHSXY PSE MWIDE ALI AYAAF

0
Rise after Fed chief's upbeat remarks

2018-07-18 theedgemarkets
(July 18): Southeast Asian stock markets rose on Wednesday, in line with broader Asia, as a bullish outlook from the U.S. Federal Reserve chairman lifted investor sentiment.
6888 AYAAY AXXTF PETFF ALI AYAAF

0
Should you buy stocks to hedge against inflation?

2018-07-17 business.inquirer.net
There is a common notion that one of the best ways to protect your money from losing its value from the effects of rising inflation is to invest it in the stock market.
AYAAY ALI AYAAF

0
Investors turn attention to earnings reports

2018-07-17 bworldonline
THE MAIN INDEX eked out last-minute gains on Tuesday after moving within a tight range as investors await the release of corporate earnings results in the coming weeks.
PSKXF BDOUY AYAAY UVRBY SECB BDOUF BDO MWP SYBJF URC PHSXY PSE MWIDE ALI UVRBF AYAAF

0
Bourse caps four-day rally amid lack of leads

2018-07-16 bworldonline
The bellwether Philippine Stock Exchange index (PSEI) snapped its four-day winning streak Monday, July 16, dropping 29.74 points or 0.4% to end at 7,369.44, while the broader all-shares index gave up 12.29 points or 0.27% to finish at 4,462.60.
SVTMF PSKXF BDOUY AYAAY SM BDOUF BDO SMIVY MWP PHSXY PSE MWIDE ALI AYAAF

0
PSEi ends four-day rally

2018-07-16 bworldonline
Local equities slumped on Monday, July 16, as the market continued to consolidate within range due to lack of catalysts.
SVTMF PSKXF BDOUY AYAAY SM BDOUF BDO SMIVY MWP PHSXY PSE MWIDE ALI AYAAF

0
ETII pursues projects in Visayas

2018-07-13 business.inquirer.net
Ecosystem Technologies International Inc. (ETII), part of the Metro Pacific Water portfolio, is eyeing projects with local governments in the Visayas in preparation for an expansion drive into Southeast Asian and African markets.
SMPH SPHXY AYAAY SPHXF SPHZF SHNG ALI AYAAF

3
Asia’s newest millionaires swap basket-case economy for fine art

2018-07-12 bworldonline
IN THE PHILIPPINES, where a fifth of the country lives beneath the poverty line, locals have a new obsession: fine art.
JBARF DSLV VIIX DGLD CSSLF VIIZ BDOUY AYAAY CS JBAXY BDOUF BDO CSGKF UGLD ZIV USLV TVIX ALI AYAAF XIV

0
Edge higher; Philippines hits near 1-month high

2018-07-12 theedgemarkets
(July 12): Most Southeast Asian stock markets edged higher on Thursday, with the Philippines touching a near one-month high and Indonesia extending gains for a fourth session, as broader Asian peers recovered slightly from the previous session's steep losses.
UOVEF PBLOF MLYBY MLYNF AYAAY 1295 U11 GIGNY 1155 G13 UOVEY GIGNF ALI AYAAF

3
Asia's Newest Millionaires Swap Basket-Case Economy for Fine Art - Bloomberg

2018-07-12 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
JBARF DSLV VIIX DGLD CSSLF VIIZ BDOUY AYAAY CS JBAXY BDOUF BDO CSGKF UGLD ZIV USLV TVIX ALI AYAAF XIV

0
PSEi bucks regional downturn, posts 1.39% gain

2018-07-11 business.inquirer.net
The local stock barometer climbed back to the 7,300 level yesterday, bucking the downturn across regional markets albeit in thin trading volume.
SMIVY PSKXF SVTMF AYAAY PHSXY SM PSE ALI AYAAF

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

CUSIP: Y0487P109